The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1412
ISSUE1412
March 18, 2013
Budesonide (Uceris) for Ulcerative Colitis
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Budesonide (Uceris) for Ulcerative Colitis
March 18, 2013 (Issue: 1412)
The FDA has approved a new extended-release formulation
of the corticosteroid budesonide (Uceris –
Santarus) for induction of remission in patients with
mild to moderate ulcerative colitis.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.